N-Palmitoylethanolamine Administration Ameliorates the Clinical Manifestation and Progression of Experimental Autoimmune Encephalomyelitis in Rodents
Experimental autoimmune encephalomyelitis in rodents (EAE) is an accepted in vivo model for immunopathogenic mechanisms underlying multiple sclerosis (MS) and tests possible treatment options because it mimics many of the disease patterns. The current treatments for delaying MS progression include c...
Main Authors: | D. Impellizzeri, R. Di Paola, A. Ahmad, R. Crupi, I. Paterniti, M. Campolo, G. Bruschetta, S. Clemente, E. Esposito, S. Cuzzocrea |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2014-05-01
|
Series: | European Journal of Inflammation |
Online Access: | https://doi.org/10.1177/1721727X1401200216 |
Similar Items
-
Traumatic brain injury leads to development of Parkinson’s disease related pathology in mice
by: Daniela Impellizzeri, et al.
Published: (2016-10-01) -
Effect of a new formulation of micronized and ultramicronized N-palmitoylethanolamine in a tibia fracture mouse model of complex regional pain syndrome.
by: Roberta Fusco, et al.
Published: (2017-01-01) -
Amelioration of experimental autoimmune encephalomyelitis by anatabine.
by: Daniel Paris, et al.
Published: (2013-01-01) -
Correction: Effect of a new formulation of micronized and ultramicronized N-palmitoylethanolamine in a tibia fracture mouse model of complex regional pain syndrome.
by: Roberta Fusco, et al.
Published: (2018-01-01) -
Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma
by: Paterniti Irene, et al.
Published: (2013-02-01)